Related Experiment Videos
Isoenzymes of creatine phosphokinase in acute myocardial infarction
Insights
Creatine phosphokinase (CPK) isoenzyme testing is crucial for diagnosing acute myocardial infarction (AMI). MB-CPK, the cardiac fraction, reliably identifies heart attacks, aiding in patient care.
Area of Science:
- Biochemistry
- Cardiology
- Diagnostic Medicine
Background:
- Acute myocardial infarction (AMI) diagnosis relies on various biomarkers.
- Creatine phosphokinase (CPK) and its isoenzymes are key indicators in cardiac diagnostics.
Observation:
- Serial CPK isoenzyme levels were analyzed in 400 definite AMI patients and 300 patients with elevated CPK from other causes.
- The cardiac-specific isoenzyme, MB-CPK, was detected in all AMI cases.
Findings:
- MB-CPK was present in all 400 AMI patients, but only in 5 of 300 non-AMI elevated CPK cases.
- Five distinct patterns of total CPK and MB-CPK levels correlated with clinical outcomes.
Implications:
- CPK isoenzyme determination is a valuable diagnostic tool for cardiac patients.
- This method enhances the accuracy of acute myocardial infarction diagnosis.
- Understanding CPK isoenzyme patterns aids in predicting clinical course.
Abstract:
Serial determinations of creatine phosphokinase (CPK) isoenzymes were performed in 400 patients with definite acute myocardial infarction (AMI). The findings were correlated with the clinical course and the findings in another 300 cases of increased CPK levels. MB-CPK, the cardiac fraction, was present in all 400 cases of AMI and in only 5 cases of the 300 patients with high CPK due to causes other than AMI. Based on the magnitude and time course of the total CPK in relation to the MB-CPK, five different patterns are described which correlate with the clinical course. Our findings thus suggest that the determination of CPK isoenzymes can be a most helpful diagnostic tool in the care of the cardiac patient.